Krishna Institute of Medical Sciences Limited

NSEI:KIMS 株式レポート

時価総額:₹166.8b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Krishna Institute of Medical Sciences 配当金

配当金 基準チェック /06

Krishna Institute of Medical Sciences配当金を支払った記録がありません。

主要情報

n/a

配当利回り

n/a

配当性向

業界平均利回り0.4%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
一株当たり利益₹38.75
3年後の配当利回り予想0.3%

最近の配当金アップデート

更新なし

Recent updates

Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon

Jun 12
Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon

Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?

Apr 28
Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?

We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)

Apr 10
We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)

Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Feb 29
Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 08
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Jan 23
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Nov 21
Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Aug 23
Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Aug 02
Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Apr 01
Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Dec 14
Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Aug 13
Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Aug 12
Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Jul 02
Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

May 08
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

決済の安定と成長

配当データの取得

安定した配当: KIMSの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: KIMSの配当金が増加しているかどうかを判断するにはデータが不十分です。


配当利回り対市場

Krishna Institute of Medical Sciences 配当利回り対市場
KIMS 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (KIMS)n/a
市場下位25% (IN)0.3%
市場トップ25% (IN)1.1%
業界平均 (Healthcare)0.4%
3年後のアナリスト予想 (KIMS)0.3%

注目すべき配当: KIMSは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: KIMSは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。


株主への利益配当

収益カバレッジ: KIMSの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。


株主配当金

キャッシュフローカバレッジ: KIMSが配当金を報告していないため、配当金の持続可能性を計算できません。


高配当企業の発掘